Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001905156 | SCV002131487 | uncertain significance | not provided | 2021-06-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gly142Valfs*12) in the ALPK3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 1766 amino acid(s) of the ALPK3 protein. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with ALPK3-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. |